[
  {
    "ts": null,
    "headline": "Viatris Stock: Analyst Estimates & Ratings",
    "summary": "Viatris has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=cbdc695250e0605744934f64727ba3d02427a44ec6aba79fd8bde559a61a8006",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754397438,
      "headline": "Viatris Stock: Analyst Estimates & Ratings",
      "id": 136212872,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=cbdc695250e0605744934f64727ba3d02427a44ec6aba79fd8bde559a61a8006"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Announces Quarterly Dividend",
    "summary": "Viatris Inc. (Nasdaq: VTRS) today announced that on August 4, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on September 15, 2025, to shareholders of record as of the close of business on August 22, 2025.",
    "url": "https://finnhub.io/api/news?id=36dde36884e3ebadf2f0311ef0be3de86732e78485e674c6b6f34ddd744dde8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391540,
      "headline": "Viatris Announces Quarterly Dividend",
      "id": 136212873,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS) today announced that on August 4, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on September 15, 2025, to shareholders of record as of the close of business on August 22, 2025.",
      "url": "https://finnhub.io/api/news?id=36dde36884e3ebadf2f0311ef0be3de86732e78485e674c6b6f34ddd744dde8a"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Announces Appointment of David Simmons to the Company's Board of Directors",
    "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that David Simmons has been appointed as the newest member of Viatris' Board of Directors.",
    "url": "https://finnhub.io/api/news?id=cdba5b6fa5898838b6f6a674eccbeb3da0e7c86fd7947e9e777ab6bfdc162c7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391300,
      "headline": "Viatris Announces Appointment of David Simmons to the Company's Board of Directors",
      "id": 136212371,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that David Simmons has been appointed as the newest member of Viatris' Board of Directors.",
      "url": "https://finnhub.io/api/news?id=cdba5b6fa5898838b6f6a674eccbeb3da0e7c86fd7947e9e777ab6bfdc162c7a"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Paracetamol Market size & share revenue was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach around USD 1460.23 Million by 2034, at a CAGR of 5.24% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson, GlaxoSmith",
    "url": "https://finnhub.io/api/news?id=c7d1109c438b8050a8192b1a1bc9cf967ec72ac8f304656e2b168e9f1d2dec1d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754368200,
      "headline": "[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",
      "id": 136205748,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Paracetamol Market size & share revenue was valued at approximately USD 876.48 Million in 2024 and is expected to reach USD 922.41 Million in 2025 and is expected to reach around USD 1460.23 Million by 2034, at a CAGR of 5.24% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Johnson & Johnson, GlaxoSmith",
      "url": "https://finnhub.io/api/news?id=c7d1109c438b8050a8192b1a1bc9cf967ec72ac8f304656e2b168e9f1d2dec1d"
    }
  }
]